Clarius Ejection Fraction AI

by Clarius Mobile Health Corp.  · Based in Canada → — AI-powered ultrasound for automated left ventricular ejection fraction calculation.
Cardiology Critical Care Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

Clarius Ejection Fraction AI is an intelligent, real-time cardiac assessment tool integrated directly into the Clarius Ultrasound App. It automates the calculation of left ventricular ejection fraction (LVEF), a key indicator of heart pumping efficiency, to remove subjectivity and accelerate diagnosis using ultrasound at the point of care. The tool was developed using thousands of cardiac ultrasound images annotated by clinicians to support consistent LVEF assessment across a range of patient presentations and image qualities. It is designed to provide objective, data-driven diagnoses in seconds, addressing the historical reliance on subjective visual estimation or the need for specialized sonography expertise and formal echocardiography.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated LVEF calculation
  • Real-time display of EF percentage
  • Removes subjectivity in cardiac assessment
  • Accelerates diagnosis
  • Seamless integration into Clarius App
  • Works across multiple cardiac views
  • High accuracy across various patient body types and image qualities
  • Supports consistent LVEF assessment
  • AI-guided training mode (T-Modeu2122 Heart) for anatomy recognition
  • PDF reports with key cardiac values

Use Cases

  • Real-time cardiac assessments at the point of care
  • Evaluating undifferentiated shortness of breath
  • Assessing septic shock
  • Trauma evaluation
  • Cardiac monitoring in rural or underserved communities
  • Early detection of heart failure and guiding medical therapy

What Physicians Need to Know

Echocardiography AI Features
Clarius Ejection Fraction AI automatically calculates and displays the left ventricular ejection fraction (LVEF) percentage in real-time from standard cardiac ultrasound views. It was developed using thousands of cardiac ultrasound images annotated by clinicians to ensure consistent LVEF assessment across various patient presentations and image qualities. This tool provides high-accuracy EF results and removes the subjectivity often associated with traditional visual estimation of LV function.
Heart Failure Risk Prediction
By identifying a decline in ejection fraction, particularly a drop below 40% which may indicate heart failure, the tool enables physicians to trigger guideline-directed medical therapy and informed specialist referrals earlier. This can serve as a longitudinal marker of disease progression.
Cardiac Monitoring Integration
The AI is integrated directly into the Clarius Ultrasound App, providing a seamless workflow from placing the probe on the patient to obtaining the LVEF result. It is available to users of Clarius PA, PAL, and C3 HD3 wireless ultrasound scanners via the latest app update.
AHA/ACC Guideline Alignment
The tool supports early identification of a decline in EF, which can help physicians initiate guideline-directed medical therapy for potential heart failure patients.
Real-Time Alert Capability
Clarius Ejection Fraction AI delivers actionable information in real-time, within the 90-second window often required for resuscitation guidance in emergency and critical care settings. It assists in evaluating conditions like undifferentiated shortness of breath, septic shock, and trauma, providing precise, real-time cardiac data for fluid resuscitation and medication initiation.
Physician Tip

Clarius Ejection Fraction AI offers an objective and rapid assessment of left ventricular function, which is particularly beneficial in high-pressure environments like emergency and critical care settings where timely data is crucial for guiding resuscitation and treatment. For primary care physicians, who may lack specialized training in interpreting LV function, this AI tool provides a valuable, objective marker for disease progression, enabling earlier intervention and specialist referrals when a decline in EF is detected. The ability to calculate EF across multiple cardiac views adds flexibility and practicality in real-world scanning scenarios.

Clarius Ejection Fraction AI is integrated directly into the Clarius Ultrasound App and is accessible to users of Clarius PA, PAL, and C3 HD3 wireless ultrasound scanners through a software update. Access to this and other Clarius Intelligence tools is available to users with a Clarius Membership or One-Time Licenses.

Details

Category Cardiology AI
Pricing Contact for pricing — Access available with Clarius Membership or One-Time Licenses
DeploymentMobile App (integrated with Clarius Ultrasound App)
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated

Clarius Ejection Fraction AI received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on June 2, 2026.

Integrations
EHR Not specified
Specialties Cardiology, Critical Care, Radiology

What the Web Says

Clarius Ejection Fraction AI is an FDA-cleared software integrated into Clarius wireless ultrasound scanners that provides automated, real-time calculation of left ventricular ejection fraction (LVEF). This AI tool aims to reduce the subjectivity and high level of sonography expertise traditionally required for cardiac function assessment, making it more accessible for clinicians in various settings, including emergency and critical care, and potentially improving access to cardiac monitoring in underserved communities.

Overall: Positive

Strengths

  • Automated and objective LVEF calculation, reducing operator dependence and variability.
  • Real-time results, providing actionable information quickly, especially crucial in emergency settings.
  • Works across multiple cardiac views, offering flexibility in real-world scanning.
  • Trained on thousands of cardiac ultrasound images, leading to accurate assessments despite variations in image quality and patient body types.
  • Improves access to cardiac monitoring in rural and underserved communities.
  • User-friendly and easy-to-use software with good quality images.

Limitations

  • Pricing information was not fully verified.
  • Detailed source review for privacy, security, and compliance pages is still needed.
  • Implementation fit depends on local workflow, integrations, and contract terms.
  • Some users of Clarius devices (which host the AI) have reported issues with poor wireless connection and slow frame rates, particularly with Android devices.
  • Initial connection time can be a pain point for the wireless Clarius devices.

Based on reviews from: Clarius PAL HD3 Review: The AI Handheld Ultrasound That Teaches You While You Scan, Clarius Ejection Fraction AI Review & Alternatives - HealthAIdir, FDA Clears AI Ultrasound Software for Automated LVEF Calculation | Diagnostic Imaging, FDA OKs Clarius' Ejection Fraction AI for Cardiac Ultrasound - Medical Product Outsourcing, FDA Clears Clarius Ejection Fraction AI to Deliver Objective, Real-Time Cardiac Ultrasound Assessments - Diagnostic and Interventional Cardiology, FDA Clears Clarius Ejection Fraction AI to Deliver Objective, Real-Time Cardiac Ultrasound Assessments for Primary Care and Emergency Medicine - PR Newswire, Clinical Validation of an Artificial Intelligenceu2013Based Tool for Automatic Estimation of Left Ventricular Ejection Fraction and Strain in Echocardiography: Protocol for a Two-Phase Prospective Cohort Study - PMC, Clarius : r/pocus - Reddit, Handheld US: Butterfly vs Clarius? : r/medicine - Reddit, Harnessing the Power of AI: A Comprehensive Review of Left Ventricular Ejection Fraction Assessment With Echocardiography - PubMed, What Three ER Physicians Say About the New Clarius PAL Dual-Array Ultrasound Scanner, Artificial Intelligence-Assisted Point-of-Care Ultrasound for Evaluating Left Ventricular Ejection Fraction: A Systematic Review of Prospective Observational Studies - PubMed, Clarius Ultrasound App - Ratings & Reviews, Best handheld ultrasound machine in the market now? : r/emergencymedicine - Reddit, AI-Assisted LVEF Assessment Using a Handheld Ultrasound Device: A Single-Center Comparative Study Against Cardiac Magnetic Resonance Imaging - PMC, Artificial Intelligence in Cardiac Point-of-Care Ultrasound: A Narrative Review - PubMed

Last updated: 2026-08-19

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Clarius Ejection Fraction AI

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

PR Newswire
FDA Clears Clarius Ejection Fraction AI to Deliver Objective, Real-Time Cardiac Ultrasound Assessments for Primary Care and Emergency Medicine
Clarius Mobile Health announced FDA clearance for its new Ejection Fraction (EF) AI, an intelligent cardiac assessment tool integrated into the Clarius Ultrasound App for automated, objective measurement of left ventricular function. This AI tool aims to remove subjectivity and accelerate diagnosis in cardiac ultrasound at the point of care.
2026-06
Medical Product Outsourcing
FDA OKs Clarius' Ejection Fraction AI for Cardiac Ultrasound
Clarius Mobile Health received U.S. FDA clearance for its Ejection Fraction (EF) AI, a tool that automatically calculates and displays EF percentage in real-time from cardiac ultrasound images. This technology aims to provide objective measurements of left ventricular function, reducing reliance on subjective visual estimation.
2026-06
Diagnostic and Interventional Cardiology
FDA Clears Clarius Ejection Fraction AI to Deliver Objective, Real-Time Cardiac Ultrasound Assessments
Clarius Mobile Health's new Ejection Fraction (EF) AI, cleared by the FDA, is integrated into the Clarius App to automate LVEF calculation, providing objective, real-time cardiac ultrasound assessments. This tool is designed to remove subjectivity and speed up diagnosis at the point of care.
2026-06
Radiology Signal
Clarius Ejection Fraction AI gains FDA clearance
Clarius Ejection Fraction AI, a software integrated into the Clarius Ultrasound App, has received FDA clearance for semi-automated cardiac ultrasound assessments.
2026-06
FDA
Artificial Intelligence-Enabled Medical Devices
The FDA lists Clarius Ejection Fraction AI by Clarius Mobile Health Corp. as an AI-enabled medical device cleared on February 27, 2026, under product code QIH for Radiology.
2026-02
InBC
InBC Portfolio News & Updates: July 2026 Edition
Clarius Mobile Health's Ejection Fraction (EF) AI has been cleared by the FDA, providing an intelligent cardiac assessment tool that integrates with the Clarius Ultrasound App for automated, objective measurement of left ventricular function.
2026-07
Rhizome AI
FDA Regulation of Post-Market Algorithm Changes: Predetermined Change Control Plans for AI/ML-Enabled Devices
Clarius Ejection Fraction AI is listed with FDA clearance K253593, allowing for the addition of data from current and future cleared Clarius scanners under a predetermined change control plan.
2026-08
PR Newswire
Clarius Mobile Health Announces Historic 2025: Achieves Profitability, Double-Digit Growth, and New FDA Clearances for Ultrasound AI
Clarius Mobile Health announced FDA clearance for its Ejection Fraction AI as part of its historic 2025 achievements, which also included profitability and double-digit growth.
2025-12

Videos

Product demos, reviews, and walkthroughs for Clarius Ejection Fraction AI.

View all on YouTube

Frequently Asked Questions

Clarius Ejection Fraction AI is designed for seamless integration. It operates on the Clarius C3 HD3 ultrasound scanner, providing real-time EF calculations at the point of care. The results can be easily exported and integrated into your EMR system through standard DICOM or other compatible formats, minimizing disruption to your current workflow.
Clarius Ejection Fraction AI is a CE-marked and FDA-cleared device, ensuring it meets stringent regulatory requirements for medical devices. It has undergone rigorous validation studies to demonstrate its accuracy and reliability in calculating ejection fraction, providing physicians with confidence in its clinical utility.
Clarius Ejection Fraction AI has demonstrated high accuracy in comparison to traditional, manual methods of EF calculation, often showing strong correlation with expert readings. While highly effective, its limitations can include image quality dependency, particularly in technically difficult studies, and it is not intended to replace comprehensive physician interpretation.
Clarius Ejection Fraction AI is typically offered as a software add-on to the Clarius C3 HD3 ultrasound scanner. Pricing models often involve a one-time purchase for the AI feature or a subscription-based model, which may include ongoing updates and support. Specific pricing details can be obtained through a Clarius representative.
Yes, there are other AI-powered EF tools on the market, often integrated into cart-based ultrasound systems or as standalone software. Clarius Ejection Fraction AI differentiates itself by offering a highly portable, handheld solution with real-time capabilities, making it particularly suitable for point-of-care applications and situations where mobility is crucial.
Clarius provides comprehensive training resources, including online tutorials, webinars, and user manuals, to help physicians effectively integrate and utilize the Ejection Fraction AI. Additionally, dedicated customer support is available to address any technical questions or operational concerns.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

More from Clarius Mobile Health

Clarius AI
Clarius Mobile Health
Cardiology AI
Clarius AI is a suite of artificial intelligence features integrated into Clarius Mobile Health's handheld ultrasound scanners and app, designed to enhance image quality, automate measurements, and provide real-time guidance for clinicians across various specialties.
Clarius Bladder AI
Clarius Mobile Health
Clinical Decision Support & Reference
Clarius Bladder AI is a non-invasive, AI-powered tool that automatically and accurately measures bladder volume in seconds using Clarius HD3 wireless handheld ultrasound scanners, providing real-time feedback to clinicians.
Clarius Median Nerve AI
Clarius Mobile Health
Neurology AI
Clarius Median Nerve AI is an FDA-cleared, AI-powered tool within the Clarius Ultrasound App that assists clinicians in real-time localization and measurement of the median nerve for Carpal Tunnel Syndrome assessments using handheld ultrasound scanners.
Clarius OB AI
Clarius Mobile Health
OB/GYN AI
Clarius OB AI is an FDA-cleared, AI-powered fetal biometric measurement tool that integrates with Clarius handheld ultrasound scanners to automate fetal measurements, making prenatal monitoring more accessible and user-friendly for healthcare professionals.

View company profile →

Suggest an Edit → | Last Verified: 2026-08-19 | First Added: 2026-08-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.